Natural killer cells in children with acute leukemia. The effect of interleukin-2

Publisher Website
Google Scholar
Abstract
The purpose of this study was to determine (1) the number and activity of natural killer (NK) cells in children with acute leukemia at different stages of their disease; and (2) the effect of interleukin‐2 (IL‐2) in enhancing NK activity of these patients' cells. The mean percentage of Leu 11+ NK cells in patients at diagnosis (5% of peripheral blood (PB) mononuclear cells) was significantly lower than for patients on maintenance (23%), post‐treatment (21%) and for normal children (20%). The mean PB NK cell cytotoxicity for patients at diagnosis (16% lysis versus K562) and during maintenance (20%) was significantly lower than for post‐treatment (41%) and normal controls (40%). After NK cells were incubated for 5 days with IL‐2, NK cells from 82% (36/44) of patients showed enhanced cytotoxicity toward K562 and several acute leukemia cell lines as well as toward autologous leukemic cells. Cytotoxicity toward autologous cells was very low (0% to 5%, 16 hour assay) before IL‐2 stimulation, and significantly increased (23% to 69%) after stimulation, suggesting that IL‐2 may be a useful agent for enhancing the antileukemic immune response.